Human Umbilical Cord Blood Progenitors: The Potential of These Hematopoietic Cells to Become Neural

The mononuclear fraction from human umbilical cord blood (HUCB) contains a significant number of stem/progenitor cells that in theory could be come any cell in the body, including neurons. Taking into consideration that transdifferentiation would be a very rare event and also knowing that overlappin...

Full description

Saved in:
Bibliographic Details
Published inStem cells (Dayton, Ohio) Vol. 23; no. 10; pp. 1560 - 1570
Main Authors Chen, Ning, Hudson, Jennifer E., Walczak, Piotr, Misiuta, Iwona, Garbuzova‐Davis, Svitlana, Jiang, Lixian, Sanchez‐Ramos, Juan, Sanberg, Paul R., Zigova, Tanja, Willing, Alison E.
Format Journal Article
LanguageEnglish
Published Bristol John Wiley & Sons, Ltd 01.11.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The mononuclear fraction from human umbilical cord blood (HUCB) contains a significant number of stem/progenitor cells that in theory could be come any cell in the body, including neurons. Taking into consideration that transdifferentiation would be a very rare event and also knowing that overlapping genetic programs for hematopoiesis and neuropoiesis exist, we undertook a characterization of the HUCB mononuclear fraction, including analysis of cellular subpopulations and their morphology, cell viability, proliferation, and expression of neural and hematopoietic antigens. Two cell populations were apparent—adherent and floating fractions. The adherent fraction was mainly lymphocytes (∼53%) expressing hematopoietic antigens. Upon replate, the floating population had many cells that expressed stem cell antigens. More of the cells in this subfraction expressed neural proteins. Neurotrophin receptors trkB and trkC were present in both cell fractions, although expression was higher in the floating fraction. Our initial characterization suggests that a subpopulation of cells exists within the HUCB mononuclear fraction that seems to have the potential to become neural cells, which could then be used in the development of cell‐based therapies for brain injuries and diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1066-5099
1549-4918
DOI:10.1634/stemcells.2004-0284